与FT共进午餐

Biotech billionaire Kiran Mazumdar-Shaw: ‘I’ve always been very unconventional’
生物科技亿万富豪基兰•马祖姆达‑肖:”我一直都不走寻常路“

The Biocon founder on building an Indian corporate powerhouse, weight-loss drugs — and how to get Bengaluru moving again
Biocon创始人谈如何打造印度企业巨头、减重药物,以及如何让班加卢鲁再次运转起来。

Overcompensating for the notorious traffic of Bengaluru, India’s technology capital still widely known by its former name Bangalore, I arrive 20 minutes early for lunch with biologics billionaire Kiran Mazumdar-Shaw. Her impatience with her home city’s congestion is well known, and as my Uber inches along and motorbikes mount pavements to bypass the gridlock, it is easy to see where she is coming from.

为了应对印度科技之都班加卢鲁(Bengaluru,旧称班加罗尔)臭名昭著的交通,我提前了20分钟到达了与生物制药亿万富翁基兰•马宗达-肖(Kiran Mazumdar-Shaw)共进午餐的地点。人们都知道她对这座家乡城市的拥堵早已深恶痛绝;当我的优步车一点点向前挪动、摩托车骑上人行道绕过车阵时,很容易理解她为何会这样想。

您已阅读3%(566字),剩余97%(21497字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×